A group of researchers from University of Puerto Rico, including Karla Claudio, Dr. Jorge Duconge and Dr. Carmen Cadilla, advance the field of pharmacogenetics by researching how different genetic mutations help or hinder the metabolization of warfarin.

This article is available in Spanish.